Published in

Oxford University Press, Clinical Infectious Diseases, 1(75), p. e905-e908, 2022

DOI: 10.1093/cid/ciab1062

Links

Tools

Export citation

Search in Google Scholar

Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities

Journal article published in 2022 by Xin Li ORCID, Jacky Man Chun Chan, Bosco Lam, David Christopher Lung, Kwok Cheung Lung, Christina Kin Yi Chow, Tracey Tam, Kelvin Hei Yeung Chiu ORCID, Ling Lung Hung, Ivan Fan Ngai Hung, Vincent Chi Chung Cheng, Kelvin Kai Wang To, Kwok Yung Yuen
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Abstract This retrospective study of incoming travelers with coronavirus disease 2019 showed that individuals immunized by messenger RNA vaccines had significantly longer postvaccination intervals (median, 30.5 days) to breakthrough infection, lower white blood cell counts and lactate dehydrogenase levels on admission, and fewer radiographic abnormalities than those immunized by inactivated virus vaccine, who paradoxically had lower respiratory viral load.